Clinical trial

A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors

NCT01764087

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-12-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2012-12-01Date precision: month

Registry last updated2015-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Gastric Cancerunresolved

Breast Cancerunresolved

Interventions

KX2-391 and PaclitaxelDRUG

Sponsors & collaborators

Hanmi Pharmaceutical Company Limitedlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01764087 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.